Browse Articles

Discover research articles across all indexed journals

Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS

Blood He Tian Tony Chen, Pratik Joshi, Severine Cathelin et al. Jun 18, 2026 DOI: 10.1182/blood.2025030731

Myelodysplastic neoplasms (MDS) feature hematopoietic deficits driven in part by transcript splicing abnormalities. Thus far, such disease-driving transcripts have been identified in association with specific splicing factor mutations. However, conserved aberrant splicing-derived transcripts that drive MDS independently of mutational status remain poorly studied despite representing global therapeutic targets. Here, we characterize an MDS-associated MBD1 isoform (MBD1-L) as a novel member of this class of transcripts. Rather than originating from a mutant splicing factor, the abnormal production of MBD1-L is driven by reduced WTAP expression in MDS. Overexpression of MBD1-L in healthy human HSPCs recapitulates archetypal MDS defects, including reduced terminal GLYA+ erythroid differentiation, suppressed cell cycling and impaired in vivo reconstitution capacity during increased hematopoietic demand in xenotransplantation assays. An integrated multiomics approach assessing DNA binding of MBD1 isoforms, and resulting changes in chromatin accessibility, histone mark deposition and transcriptional changes, revealed that these defects arise from an isoform-specific switching of MBD1's binding behavior. The MBD1-L isoform refocuses MBD1-L's heterochromatin-promoting activity from methylated to unmethylated CpGs and thus enacting broad downregulation of CpG-rich promoters as well as secondary epigenetic effects mediated by its downstream target BCOR. Remarkably, we also find that directly reversing abnormal MBD1 splicing across a broad range of primary human MDS samples using nanoparticle-encapsulated ASOs enhances in vitro erythroid differentiation, supporting the utility of RNA therapies for MDS treatment. Thus, our findings demonstrate MBD1-L to be a global, disease-driving splice variant across MDS, and illustrate the potential for RNA-based therapies in the broad treatment of MDS.

Domain-specific contexts promote model-based decision making for basketball players

Scientific Reports Liu Yang, Chenglin Zhou, Biao Sang Jun 18, 2026 DOI: 10.1038/s41598-026-54649-z

Abstract Decision-making is a critical component of basketball performance. Within the framework of Reinforcement Learning (RL), understanding the environment and task structure can facilitate model-based (MB) behavior. This study tested whether domain-specific contexts promote MB decision strategies by using the two-stage task in a 2 (Group: basketball players vs. novices) × 2 (Condition: abstract symbols vs. basketball tactical diagrams) mixed design. Thirty-five national basketball players and twenty-seven novices completed both conditions. A hierarchical one-trial-back logistic regression estimated intercept, reward, transition, and reward × transition coefficients; two-factor repeated-measures ANOVAs assessed coefficients, reaction times, and subjective evaluations. Compared to novices, basketball players exhibited a more MB decision-making strategy across all condition, accompanied by higher subjective understanding. Novices exhibited higher reward coefficients indicated a more model-free (MF) tendency. For basketball players, MB strategies were associated with longer RTs, yet longer RTs in novices did not necessarily indicate MB strategies use. These findings show that expertise facilitates the integration of outcome feedback with the task’s structure, thereby leading to MB decision-making. Incorporating sport-specific displays into training may enhance decision-making performance without relying on explicit structural instruction.

The Bacillus subtilis circadian clock coordinates intricate spatiotemporal organisation

Nature Communications Jack Dorling, Francesca Sartor, Borja Ferrero-Bordera et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74082-0

Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis

Blood Michael Oertel, Bouthaina Dabaja, Dennis Görlich et al. Jun 18, 2026 DOI: 10.1182/blood.2025032050

Abstract Radiotherapy is an established treatment for low-grade primary cutaneous B-cell lymphoma. Recommendations on its use differ internationally, which prompted our group to conduct this analysis. Twenty-two institutions participated in this international study. Patient eligibility required a diagnosis of limited (T1/T2) primary cutaneous marginal zone or follicle center lymphoma treated with radiotherapy between 1995 and 2023. Data were collected retrospectively until February 2024 within the framework of the International Lymphoma Radiation Oncology Group. Overall, 535 patients were analyzed. Predominant locations were the head (40%) and trunk (36%). Radiotherapy had a median dose of 24 Gy in fractions of 2 Gy. Complete responses were observed in 91% at a median time of 3.6 months following radiotherapy. There was no statistically significant difference between treatments ≤4 Gy and >4 Gy for complete or overall response rates (P = .077 and P = .056, respectively). However, there was an inferior duration of local control with ≤4 Gy (5-year local control 73% ± 12% vs 96% ± 2%; P< .001). Radiation dose was the main prognostic factor in the univariate and multivariable Cox analysis; however, higher doses did not translate into an overall survival benefit. Toxicities rarely exceeded grade 2 but were more frequent in the >4 Gy group. Radiotherapy remains an effective treatment option for indolent skin lymphoma with low toxicity. High response rates are observed with low doses of ≤4 Gy. In comparison to conventional doses, these treatments have a shorter duration of local control but a favorable toxicity profile.

Motion perception and biological motion processing in adults born with extremely low birth weight

Scientific Reports Martin Johansson, Olga Kochukhova, Maria Heyman et al. Jun 18, 2026 DOI: 10.1038/s41598-026-58361-w

Abstract Individuals born with extremely low birth weight (ELBW, ≤ 1000 g) are at increased risk for long-term visual perceptual difficulties. Biological motion processing enables processing of animate and socially relevant movement. Studies of children born very preterm have found deficits in biological motion processing, but this has not previously been studied in adults born with ELBW. We compared biological and scrambled motion processing between ELBW and full-term controls and related motion processing with early neurodevelopmental level. Thirty-eight adults born ELBW and 29 controls from a regional longitudinal cohort completed eye-tracking tasks assessing biological and scrambled motion detection and biological motion interpretation accuracy. Stimuli were presented with varying levels of visual noise to manipulate task difficulty. The ELBW group showed slower biological motion and scrambled motion detection overall. Lower biological motion interpretation accuracy was observed in the ELBW group in the low noise condition, although no significant group × noise interaction was found. Exploratory unadjusted analyses suggested that poorer early neurodevelopmental outcome in toddlerhood may be associated with poorer biological motion processing in adulthood, although these associations did not remain significant after for multiple-comparisons adjustment. These findings suggest that adults born ELBW show less efficient motion perception than controls in adulthood.

Optical access of spin-polarized excited states in Cs(PbMgZnCd)Br3 nanocrystals

Nature Communications Yu Zhang, Haidi Liu, Shuchun Zhang et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74479-x

Ticks and transfusions: a potentially fatal mix!

Blood Sheryl van Nunen Jun 18, 2026 DOI: 10.1182/blood.2026033810

Sustainable biodiesel from an invasive fish using immobilized lipase on magnetic nanogels as a novel management approach

Scientific Reports Gülşah Saç, Gökmen Arabacı, Aleyna Çağan et al. Jun 18, 2026 DOI: 10.1038/s41598-026-56598-z

Monocarboxylate transporter 2 regulates maintenance of myelin and axonal integrity by oligodendrocytes

Nature Communications Leire Izagirre-Urizar, Luna Mora-Huerta, Irene Soler-Saez et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74488-w

Platelets under pressure: a sticky outside-in problem

Blood Gowtham K. Annarapu, Sruti Shiva Jun 18, 2026 DOI: 10.1182/blood.2026034069

Enhancing performance of gravitational water vortex turbines through airfoil design and basin parameters

Scientific Reports Miral Michel, Abdelmenaim Hatim Alaktaa, Khaled Elsherbiny et al. Jun 18, 2026 DOI: 10.1038/s41598-026-56885-9

Abstract Gravitational water vortex turbines (GWVTs) have emerged as promising hydrokinetic technology for energy extraction in riverine systems characterized by low flow velocity and ultra-low head, where conventional hydropower solutions are not feasible. In this study, a three-dimensional computational fluid dynamics (CFD) model is developed to investigate turbine performance within a conical basin configuration. The numerical framework, validated against published reference data, is used to systematically evaluate the influence of airfoil axial spacing, chord sizing, and airfoil profile, on vortex structure and power coefficient. The results demonstrate that basin-induced flow control plays a critical role in enhancing tangential momentum transfer to the rotor. Among the investigated cases, a configuration employing a NACA0024 ducted airfoil with a chord size of 35 mm and an axial spacing of 50 mm yielded the highest power coefficient of 0.419 compared to the baseline basin power coefficient of 0.313 and reached a maximum value of 0.736 at higher inlet velocities. Performance analysis based on tip speed ratio (TSR) further identified an optimal low-TSR operating range consistent with gravitational water vortex turbine characteristics. Compared with previous GWVT studies that focus on turbine geometry, the present work highlights the effectiveness of basin wall airfoil design as an impactful strategy for performance enhancement in low-head hydrokinetic applications.

Stewardship without walls: taming the unregulated antibiotic economy to contain antimicrobial resistance in Ethiopia

Nature Communications Balew Arega, Asnake Agunie Jun 18, 2026 DOI: 10.1038/s41467-026-74671-z

Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial

Blood Armin Riecke, Sandra Robrecht, Deyan Yordanov Yosifov et al. Jun 18, 2026 DOI: 10.1182/blood.2025032806

Watch & wait is the standard of care in asymptomatic early-stage chronic lymphocytic leukemia (CLL). The CLL12 trial investigated ibrutinib versus placebo in early-stage patients with intermediate to very high risk of progression, showing improved event-free survival (EFS) but no overall survival (OS) benefit10. Building on these findings, our analysis examined whether a significant benefit could be identified within distinct genetic subgroups. After a median follow-up of 69.3 months, there were 166 EFS and 32 OS events in 515 trial patients. In the placebo arm, del(17p), del(11q), +12, U-IGHV, and mutations in NOTCH1, ATM, NRAS/KRAS/BRAF, and NFKBIE correlated with shorter EFS. With ibrutinib, only del(17p) and TP53 and NFKBIE mutations significantly compromised EFS. Ibrutinib offered substantial EFS benefit in subgroups with U-IGHV, del(11q), +12, NOTCH1, ATM, and NFKBIE mutations. No EFS improvement was seen for asymptomatic early-stage patients with del(17p) or TP53 mutations. Ibrutinib provided no OS benefits in any genetic subgroup. Multivariable analysis revealed ibrutinib treatment as an independent favorable factor for EFS, while U-IGHV, del(17p), POT1, RAS/RAF, and NFKBIE mutations were adverse prognostic factors. The results confirm watch-and-wait as standard of care for early-stage CLL patients, especially in high-risk CLL characterized by del(17p) and/or mutated TP53. EudraCT Number: 2013-003211-22

Synthesis, structure, fluorescence properties and catalytic application of uranyl complexes supported by salen ligands

Scientific Reports S. Nakul, Varad Mahesh Phadke, I. Ayisha et al. Jun 18, 2026 DOI: 10.1038/s41598-026-57706-9

Ductile and scalable 3 GPa steel via a hierarchical microstructural architecture

Nature Communications Ruming Geng, Yue Liu, Peiwen Tang et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74216-4

The 10-year RELEVANCE trial analysis

Blood Jun 18, 2026 DOI: 10.1182/blood.2026034593

Valorization of agro-industrial and forestry biomass ashes as soil amendments: integrating chemical screening, leaching dynamics, and Beta vulgaris L. response

Scientific Reports Magdalena Oleksy-Sobczak, Andrzej Baryga, Łukasz Ściubak et al. Jun 18, 2026 DOI: 10.1038/s41598-026-58403-3

Abstract Sustainable management of biomass combustion ash is critical for circular economy transitions. This study provides a comprehensive evaluation of six biomass ashes (wood chips, forest residues, maize cobs, plum pits, sugar beet pulp, and distillery decoction) as potential soil amendments. Chemical characterization and leaching tests revealed high concentrations of Ca, K, Mg, and P, confirming significant agronomic potential. However, ashes from beet pulp and distillery decoction exceeded EU arsenic limits by up to 5.5-fold, with distillery decoction ash releasing 69% of its As during leaching. A pot experiment with Beta vulgaris L. demonstrated that ash application at 2–8 Mg ha⁻¹ consistently increased soil pH and enhanced fresh biomass by up to 59%, particularly when combining nutrient-rich and Ca-rich ashes. Nevertheless, high application rates of specific blended variants increased Pb and Cd uptake in roots, likely driven by dissolved organic carbon (DOC) mobilization. These findings indicate that while biomass ashes effectively correct soil acidity and improve crop yields, their valorization requires rigorous feedstock screening and dose control to ensure regulatory compliance and food safety.

SplitSeek-Pro: accurate prediction of splittable sites on protein structures

Nature Communications Yu-Xiang Wang, Fengyi Jiang, Tingjie Xu et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74059-z

A novel G13-RAPGEF2-RAP1 signaling pathway critical for platelet adhesion and aggregation

Blood David S. Paul, David J. Rocco, Emily G. Clark et al. Jun 18, 2026 DOI: 10.1182/blood.2025032282

Abstract Hemostasis and thrombosis are strongly dependent on the unique ability of platelets to rapidly activate integrin receptors and to firmly adhere to sites of injury under shear stress conditions. Central to integrin activation is the small GTPase RAP1, which itself is activated by guanine nucleotide exchange factors (GEFs). CalDAG-GEFI (RASGRP2) is the highest expressed and functionally dominant platelet RAP-GEF. However, a genome-wide association study also suggested a significant role for RAPGEF2 (PDZ-GEFI), a low-expressed RAP-GEF, in human platelet aggregation. Here, we used mice deficient in RAPGEF2 (megakaryocyte-specific, Rapgef2mKO), CalDAG-GEFI (Caldaggef1˗/˗), or both RAPGEF2 and CalDAG-GEFI (DKO) to characterize the contribution of RAPGEF2 signaling to platelet function, hemostasis, and thrombosis. RAPGEF2 protein was detected in murine and human platelets. Compared with control or Caldaggef1˗/˗ platelets, both RAP1 activation and integrin αIIbβ3-mediated aggregation were significantly diminished in DKO platelets. When compared with controls, Rapgef2mKO platelets exhibited reduced integrin activation, a more reversible aggregation response, and impaired adhesion under conditions of shear stress ex vivo and in vivo. Mechanistic studies strongly suggest that RAPGEF2 operates downstream of receptors coupled to the heterotrimeric G protein G13 (GNA13), such as αIIbβ3 and the thromboxane receptor. Together, our studies provide genetic evidence that RAPGEF2 in platelets operates downstream of G13 as an important regulator of RAP1 signaling and integrin activation, especially under conditions of elevated shear stress. These findings markedly improve our understanding of G protein signaling and integrin function in platelets, with potential implications for the development of improved platelet-targeted therapies for cardiovascular disease.

Synergistic use of brick and ceramic wastes with polyethylene glycol in high-performance fiber-reinforced composites

Scientific Reports Ali S. Ahmed, Osama Youssf, Mohamed M. Yousry Elshikh et al. Jun 18, 2026 DOI: 10.1038/s41598-026-58428-8